Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Thrombosis and Haemostasis

• Publication date

  2013-06-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH13-03-0238PMID 23740299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

  2015cited by this paper
• Faculty Opinions recommendation of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2013cited by this paper
• Climacteric Lowers Plasma Levels of Platelet-Derived Microparticles: A Pilot Study in Pre- versus Postmenopausal Women

  2012cited by this paper
• European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)

  2012cited by this paper
• Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques

  2012influential reference
• Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin.

  2012cited by this paper
• Abstract 42: Monocyte Tissue Factor-Dependent Activation of Coagulation in Hypercholesterolemic Mice and Monkeys Is Inhibited by Simvastatin

  2012cited by this paper
• Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study.

  2012cited by this paper
• Pharmacological modulation of microparticle release: new strategies for the management of atherothrombotic vascular disorders.

  2012cited by this paper
• Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study.

  2012cited by this paper
• Single vs. swarm detection of microparticles and exosomes by flow cytometry

  2012cited by this paper
• Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice

  2012cited by this paper
• Update on lipids, inflammation and atherothrombosis

  2011influential reference
• Microparticles: An Introduction

  2011cited by this paper
• Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus

  2011cited by this paper
• MPs or ICs?

  2011cited by this paper
• Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease

  2011cited by this paper
• Progress and challenges in translating the biology of atherosclerosis

  2011cited by this paper
• Circulating CD 31 1 / Annexin V 1 microparticles correlate with cardiovascular outcomes

  2011cited by this paper
• Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner.

  2011cited by this paper
• Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)

  2011cited by this paper
• Atorvastatin and its collateral effects on microparticles

  2011cited by this paper
• Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

  2011cited by this paper
• Circulating microparticles: new insights into the biochemical basis of microparticle release and activity

  2011cited by this paper
• Microparticles, vascular function and hypertension

  2010cited by this paper
• Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis

  2010cited by this paper
• Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands.

  2010cited by this paper
• Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.

  2010cited by this paper
• Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop

  2010influential reference
• Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.

  2010cited by this paper
• Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes.

  2009cited by this paper
• The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients

  2009cited by this paper
• Lipoproteins, platelets and atherothrombosis.

  2009cited by this paper
• Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

  2009cited by this paper
• Lipoproteínas, plaquetas y aterotrombosis

  2009cited by this paper
• Familial hypercholesterolaemia: summary of NICE guidance

  2008cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent

  2008cited by this paper
• Statin and endothelial cell-derived microparticles

  2008cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Circulating platelet-derived microparticles are associated with atherothrombotic events: a marker for vulnerable blood.

  2007cited by this paper
• Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study.

  2007cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invit

  2007cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice: executive summary.

  2007cited by this paper
• Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.

  2005influential reference
• Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway.

  2005cited by this paper
• Pravastatin reduces fibrinogen receptor gpIIIa on platelet‐derived microparticles in patients with type 2 diabetes

  2005cited by this paper
• Simvastatin Versus Ezetimibe: Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans

  2005cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• The phospholipid composition and cholesterol content of platelet‐derived microparticles: a comparison with platelet membrane fractions

  2005cited by this paper
• Shed Membrane Particles From T Lymphocytes Impair Endothelial Function and Regulate Endothelial Protein Expression

  2004cited by this paper
• Effects of Losartan and Simvastatin on Monocyte-Derived Microparticles in Hypertensive Patients With and Without Type 2 Diabetes Mellitus

  2004cited by this paper
• Measuring circulating cell‐derived microparticles

  2004cited by this paper
• Intensive statin therapy--a sea change in cardiovascular prevention.

  2004cited by this paper
• Losartan and Simvastatin Inhibit Platelet Activation in Hypertensive Patients

  2004cited by this paper
• Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway.

  2004cited by this paper
• Statins and Blood Coagulation

  2004cited by this paper
• Molecular characterization of familial hypercholesterolemia in Spain: Identification of 39 novel and 77 recurrent mutations in LDLR

  2004cited by this paper
• [Coronary risk estimation in Spain using a calibrated Framingham function].

  2003cited by this paper
• Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

  2003cited by this paper
• Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesteroal concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOL-LLA): a multicentre randomised controlled trial

  2003cited by this paper
• Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada

  2003cited by this paper
• Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus

  2002influential reference
• Statin Therapy in Acute Coronary Syndromes: Mechanistic Insight Into Clinical Benefit

  2002cited by this paper
• Small GTP-binding proteins.

  2001cited by this paper
• Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation

  2001cited by this paper
• Cellular origin and procoagulant properties of microparticles in meningococcal sepsis.

  2000cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant.

  1997cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• Small GTP-binding proteins.

  1992cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Molecular and Cellular Mechanisms of Myocardial Ischemia and Reperfusion Injury: A Narrative Review

  2026cites this paper
• Statins and adhesion molecules: a review of a novel pleiotropic property of statins

  2025cites this paper
• Diversity of extracellular vesicle sources in atherosclerosis: role and therapeutic application

  2025cites this paper
• Challenges with measuring tissue factor antigen and activity in human plasma

  2024cites this paper
• Insight into endothelial cell-derived extracellular vesicles in cardiovascular disease: Molecular mechanisms and Clinical implications.

  2024cites this paper
• Cryptogenic ischemic stroke in cardiac transthyretin amyloidosis and sinus rhythm: a case report

  2024cites this paper
• Platelet-derived extracellular vesicles in cardiovascular disease and treatment – from maintaining homeostasis to targeted drug delivery

  2024cites this paper
• Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases

  2024cites this paper
• Kinetics of Circulating Extracellular Vesicles Over the 24‐Hour Dosing Interval After Low‐Dose Aspirin Administration in Patients at Cardiovascular Risk

  2023cites this paper
• Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

  2023cites this paper
• Extracellular Vesicles in Coronary Artery Disease.

  2023cites this paper
• The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function

  2023cites this paper
• Red Blood Cells and Endothelium Derived Circulating Extracellular Vesicles in Health and Chronic Heart Failure: A Focus on Phosphatidylserine Dynamics in Vesiculation

  2023cites this paper
• Pravastatin reduces plasma levels of extracellular vesicles in pregnancies at high risk of term preeclampsia

  2023cites this paper
• Anti-inflammatory Therapy Progress in Major Adverse Cardiac Events after PCI: Chinese and Western Medicine

  2023cites this paper
• Combined Effect of Omega-3 Fatty Acid and Vitamin D3 on Oxidized LDL-C and Non–HDL-C Levels in People With Vitamin D Deficiency: A Randomized Controlled Trial

  2023cites this paper
• Increased Platelet-derived Microparticles Counts is Correlated with Elevated Blood LDL Cholesterol in Acute Myocardial Infarction

  2022cites this paper
• Platelet-Released Extracellular Vesicle Characteristics Differ in Chronic and in Acute Heart Disease

  2022cites this paper
• Extracellular vesicles in atherothrombosis: From biomarkers and precision medicine to therapeutic targets

  2022cites this paper
• Platelet-derived extracellular vesicles correlate with therapy-induced nocturnal blood pressure changes

  2022cites this paper
• Endothelial Microparticles as Potential Biomarkers in the Assessment of Endothelial Dysfunction in Hypercholesterolemia

  2022cites this paper
• An Insight into Recent Advances on Platelet Function in Health and Disease

  2022cites this paper
• Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis

  2022cites this paper
• Platelet-released extracellular vesicles: the effects of thrombin activation

  2022cites this paper
• Oxidative Properties of Blood-Derived Extracellular Vesicles in 15 Patients After Myocardial Infarction

  2022cites this paper
• LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis

  2021cites this paper
• Potential application of biomimetic exosomes in cardiovascular disease: focused on ischemic heart disease

  2021cites this paper
• Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial

  2021cites this paper
• Impact of the Main Cardiovascular Risk Factors on Plasma Extracellular Vesicles and Their Influence on the Heart’s Vulnerability to Ischemia-Reperfusion Injury

  2021cites this paper
• Neutrophil microvesicles and their role in disease.

  2021cites this paper
• Microvesicles carrying LRP5 induce macrophage polarization to an anti‐inflammatory phenotype

  2021cites this paper
• Role of Microparticles in Cardiovascular Disease

  2021cites this paper
• A study of endothelial and platelet microvesicles across different hypertension phenotypes

  2021cites this paper
• Advances in studies on exosomes and microvesicles as markers of cardiovascular disease.

  2021cites this paper
• Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases

  2021cites this paper
• Effect of Statins on Platelet Activation and Function: From Molecular Pathways to Clinical Effects

  2021cites this paper
• Frail older adults show a distinct plasma microvesicle profile suggesting a prothrombotic and proinflammatory phenotype

  2020cites this paper
• Microvésicules : biomarqueurs non invasifs de l’endothélium

  2020cites this paper
• Effect of Physical Exercise on the Release of Microparticles with Angiogenic Potential

  2020cites this paper
• The Mediterranean diet decreases prothrombotic microvesicle release in asymptomatic individuals at high cardiovascular risk.

  2020cites this paper
• Novel Strategies to Combat CMV-Related Cardiovascular Disease

  2020cites this paper
• Interplay between Endoplasmic Reticulum Stress and Large Extracellular Vesicles (Microparticles) in Endothelial Cell Dysfunction

  2020cites this paper
• Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus

  2020cites this paper
• Effects of Cell-Derived Microparticles on Immune Cells and Potential Implications in Clinical Medicine.

  2020cites this paper
• Oxidized Low‐Density Lipoprotein Induces Macrophage Production of Prothrombotic Microparticles

  2020cites this paper
• Role of platelet biomarkers in inflammatory response

  2020cites this paper
• Circulating microparticles as biomarkers of stroke: A focus on the value of endothelial‐ and platelet‐derived microparticles

  2019cites this paper
• Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients With Familial Hypercholesterolemia: A Computed Tomographic Angiography Imaging Study

  2019cites this paper
• Lipid Metabolism in Dyslipidemia and Familial Hypercholesterolemia

  2019cites this paper
• Liquid Biopsy of Extracellular Microvesicles Predicts Future Major Ischemic Events in Genetically Characterized Familial Hypercholesterolemia Patients.

  2019cites this paper
• Part One: Extracellular Vesicles as Valuable Players in Diabetic Cardiovascular Diseases

  2019cites this paper
• Extracellular Vesicles as Messengers in Atherosclerosis

  2019cites this paper
• Cross-Talk between Lipoproteins and Inflammation: The Role of Microvesicles

  2019cites this paper
• Endothelial cell apoptosis and the role of endothelial cell-derived extracellular vesicles in the progression of atherosclerosis

  2018cites this paper
• BLTR1 and CD36 Expressing Microvesicles in Atherosclerotic Patients and Healthy Individuals

  2018cites this paper
• QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus

  2018cites this paper
• In the View of Endothelial Microparticles: Novel Perspectives for Diagnostic and Pharmacological Management of Cardiovascular Risk during Diabetes Distress

  2018cites this paper
• Phosphatidylserine-exposing blood cells and microparticles induce procoagulant activity in non-valvular atrial fibrillation.

  2018cites this paper
• Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles

  2018cites this paper
• Cytomegalovirus Infection in Cardiovascular Diseases

  2018cites this paper
• Endothelial cell-derived microvesicles: potential mediators and biomarkers of pathologic processes.

  2018cites this paper
• Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium

  2018cites this paper
• Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology.

  2018cites this paper
• Circulating microparticles are associated with clinical severity of persistent ST-segment elevation myocardial infarction complicated with cardiogenic shock.

  2018cites this paper
• Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases

  2018cites this paper
• Reassessment of Acute Kidney Injury after Cardiac Surgery: A Retrospective Study

  2017cites this paper
• Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans

  2017cites this paper
• The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles

  2017cites this paper
• Cell-derived microvesicles in cardiovascular diseases and antiplatelet therapy monitoring - A lesson for future trials? Current evidence, recent progresses and perspectives of clinical application.

  2017cites this paper
• Extracellular vesicles in coronary artery disease

  2017cites this paper
• Monocyte-derived circulating microparticles (CD14+, CD14+/CD11b+ and CD14+/CD142+) are related to long-term prognosis for cardiovascular mortality in STEMI patients.

  2017cites this paper
• Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology

  2017cites this paper
• Flow analysis of individual blood extracellular vesicles in acute coronary syndrome

  2017cites this paper
• Cell-Derived Microparticles/Exosomes in Neuroinflammation

  2017cites this paper
• Platelet mitochondrial dysfunction and the correlation with human diseases.

  2017cites this paper
• Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype

  2017cites this paper
• Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse

  2017cites this paper
• Elucidating the Mechanisms of Thromboembolism and Structural Arterial Disease in Children with Inflammatory Bowel Disease

  2017influential citation
• Decreased levels of procoagulant phospholipids in bleeding patients treated by vitamin K antagonists.

  2016cites this paper
• Syddansk Universitet The Impact of Lipoprotein-Associated Oxidative Stress on Cell-Specific Microvesicle Release in Patients with Familial Hypercholesterolemia

  2016cites this paper
• Adipocyte-derived extracellular vesicles: characterisation and function

  2016cites this paper
• Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis

  2016cites this paper
• University of Southern Denmark The Impact of Lipoprotein-Associated Oxidative Stress on Cell-Specific Microvesicle Release in Patients with Familial Hypercholesterolemia

  2016cites this paper
• Microparticle and Atherothrombotic Diseases.

  2016cites this paper
• CD142+/CD61+, CD146+ and CD45+ microparticles predict cardiovascular events in high risk patients following a Mediterranean diet supplemented with nuts

  2016cites this paper
• Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time.

  2016cites this paper
• Microparticles and blood cells induce procoagulant activity via phosphatidylserine exposure in NSTEMI patients following stent implantation.

  2016cites this paper
• Plasma Levels of Endothelial Microparticles Bearing Monomeric C-reactive Protein are Increased in Peripheral Artery Disease

  2016cites this paper
• The Impact of Lipoprotein-Associated Oxidative Stress on Cell-Specific Microvesicle Release in Patients with Familial Hypercholesterolemia

  2016influential citation
• The signature of circulating microparticles in heart failure patients with metabolic syndrome

  2016cites this paper
• Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease.

  2016cites this paper
• Effect of endothelin‐1 and endothelin receptor blockade on the release of microparticles

  2016cites this paper
• Infection and Microparticles may Cause Complication of Atherosclerotic Plaques

  2015cites this paper
• Roflumilast-induced Local Vascular Injury Is Associated with a Coordinated Proteome and Microparticle Change in the Systemic Circulation in Pigs

  2015cites this paper
• Clinical significance of procoagulant microparticles

  2015cites this paper
• High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis

  2015influential citation
• Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain

  2015cites this paper
• Angiogenic Microvascular Endothelial Cells Release Microparticles Rich in Tissue Factor That Promotes Postischemic Collateral Vessel Formation

  2015cites this paper
• Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques.

  2015cites this paper
• Microvesicles from platelets: novel drivers of vascular inflammation

  2015cites this paper